Aldeyra Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.96 |
Market Cap |
$163.85 M |
Shares Outstanding |
27.49 M |
Public Float |
23.66 M |
Address |
131 Hartwell Avenue Lexington Massachusetts 02421 United States |
Employees | - |
Website | http://www.aldeyra.com |
Updated | 07/08/2019 |
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. |